# ResusGPS All-Age Clinical Remediation — Release Record

**Status:** Merged to protected `main`; supervised synthetic/manikin validation and clinical-owner review remain required.

**Code PR:** [#681](https://github.com/karuejob-max/paeds_resus_app/pull/681)

**Merge commit:** `c065bb9cd925a72e73491e157e56a91434330280`

## Scope

This release hardens the actual ResusGPS and reachable training/legacy clinical content for neonatal, infant, child, adolescent, and adult contexts. It does not claim clinical validation, regulatory clearance, or unsupervised bedside readiness.

The release removes hidden age/weight defaults, makes NRP routing fail closed for incompatible delivery-room ages, protects the canonical absent-pulse reroute into CPR-GPS, adds typed per-kilogram/fixed/fixed-band/protocol-only dose semantics, and requires explicit oxygen targets instead of universal adult flow rates.

High-risk content was corrected or quarantined across anaphylaxis, respiratory emergencies, status epilepticus, DKA, septic and hypovolaemic shock, trauma, burns, neonatal resuscitation, upper-airway disease, seizure, definitive care, Quick Start, capstone simulations, course catalogue text, handover output, and legacy server recommendations. Routine IV epinephrine bolus and routine corticosteroid/biphasic-prevention claims were removed from anaphylaxis. Generic universal fluid, vasopressor, blood-product, TXA, oxygen, GCS, and antimicrobial assumptions were replaced with age-, indication-, local-protocol-, reassessment-, and senior-review-dependent wording.

The CPR-GPS architecture and command-console path remain separate. CPR-GPS remains a cognitive aid only; it is not a compression-feedback device, rhythm diagnostic, ETCO2 monitor, defibrillator controller, hospital alarm, or proof of treatment delivery.

## Validation

- Focused all-age clinical suite: **178 tests passed across 10 test files**.
- Protected PR CI: **passed**.
- Post-merge CI run [33153413013](https://github.com/karuejob-max/paeds_resus_app/actions/runs/33153413013): **passed** typecheck, clinical lint, unit and clinical engine tests, real-MySQL integration tests, Sprint 1 verification, and production build.
- Local production build: **passed**.
- Local clinical-content lint: **passed**.
- `git diff --check`: **passed**.
- Public read-only `/` and `/resus` checks: HTTP 200.
- Holistic E2E is configured as skipped and is not claimed as passed.
- No production patient, activation, QR, staff, Care Signal, clinical, smoke-test, or migration record was created or changed.

## Remaining clinical gates

1. A named clinical owner must review each high-risk content family, source guideline/version, review date, contraindications, local capability assumptions, and escalation language.
2. A labelled two-device synthetic/manikin matrix must cover NRP, PALS, adolescent transition, guarded ACLS, non-arrest XABCDE, arrest reroute, anaphylaxis, asthma, seizure, DKA, shock, trauma, burn, unknown weight, stale context, and unavailable resources.
3. Device-risk testing must cover muted audio, denied notifications, unavailable haptics, screen lock, backgrounding, process termination, poor connectivity, low storage, IndexedDB failure, and account switching.
4. Contradiction lint must remain a mandatory release gate for duplicate doses, universal oxygen claims, hidden defaults, obsolete scoring, and unsupported age routing.
5. The skipped holistic E2E path should be enabled in a disposable environment for activation/context → ResusGPS or CPR-GPS → handover → targeted role report/debrief → QI provenance.

## Release decision

This is an engineering safety-hardening release suitable for **supervised synthetic/manikin validation and clinical-owner review**. It is not yet an approval for unsupervised clinical deployment.

> This release record documents software validation. It does not replace clinical governance, local protocol approval, or supervised usability testing.

_Last updated: 2026-08-28._
